GLP-T (30mg)

Description

What is GLP-T?
GLP-T is a synthetic derivative of gastric inhibitory polypeptide (GIP) that also acts as a
glucagon-like peptide-1 (GLP-1) analogue, giving it a dual-receptor profile. Comprising 39 amino
acids, it is studied for its ability to bind both GIP and GLP-1 receptors and for the resulting
activity in pancreatic insulin-secretion pathways.

Published research on the parent compound has examined its relationship to glucose handling,
satiety signalling, adiponectin levels, and body composition in study models. These findings are
referenced here for scientific context only.

Areas of Research Interest

• Dual receptor activity — investigated for simultaneous GIP and GLP-1
  receptor activation and how that differs from single-receptor analogues such as GLP-S in
  comparative studies.
• Adipose tissue distribution — studied in research models for its
  relationship to visceral and subcutaneous adipose tissue.
• Lean tissue preservation — examined in the literature for how lean tissue
  is affected relative to adipose tissue in study models.
• Hepatic lipid content — investigated for its association with liver lipid
  levels and markers of liver function in research settings.

Handling and Storage
Lyophilised powder. Store the sealed vial refrigerated and protected from light. To be handled
only by trained laboratory personnel in an appropriate research setting.

Research Use Only
This product is sold exclusively as a research chemical for in-vitro laboratory investigation by qualified researchers. It is not a drug, not a dietary supplement, and not intended for human or veterinary consumption, diagnostic use, or any form of therapeutic application. No statement on this page should be read as medical advice or as a claim that this compound treats, prevents, or cures any condition. All findings referenced above come from published preclinical and clinical literature concerning the parent compound and are provided for scientific reference only.